BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38144631)

  • 1. Prevalence of isoniazid resistance in cases of rifampicin resistance detected on GeneXpert MTB/RIF assay.
    Katoch CDS; Peter DK; Marwah V; Kumar K; Bhati G
    Med J Armed Forces India; 2023 Dec; 79(Suppl 1):S1-S5. PubMed ID: 38144631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
    Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
    Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India.
    Krishnakumariamma K; Ellappan K; Muthuraj M; Tamilarasu K; Kumar SV; Joseph NM
    PLoS One; 2020; 15(10):e0240257. PubMed ID: 33017455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Diagnostic Utility of GeneXpert Mycobacterium tuberculosis/Rifampicin (MTB/RIF) Assay in the Suspected Cases of Tuberculous Meningitis.
    Patel S; Dadheech M; Maurya AK; Singh J; Purwar S; Rai N; Sarawagi R; Joshi A; Khadanga S
    Cureus; 2023 Apr; 15(4):e37761. PubMed ID: 37213979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GeneXpert
    Christopher PM; ; Widysanto A
    Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran.
    Atashi S; Izadi B; Jalilian S; Madani SH; Farahani A; Mohajeri P
    New Microbes New Infect; 2017 Sep; 19():117-120. PubMed ID: 28794886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients.
    Gomathi NS; Singh M; Myneedu VP; Chauhan DS; Tripathy S; Sarin R; Mohan A; Bhatnagar A; Khangembam JS; Kannan T; V Rao MV; Logani J; Dey B; Gangakhedkar RR; Swaminathan S; Singh UB
    Indian J Med Res; 2020 Nov; 152(5):482-489. PubMed ID: 33707390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt.
    Hassanin ESA; Mohamed Hussein AA; Abdelrheem SS; Dongol E; Mhsb AHA; Zahran AM; Zein M; G Sayed I
    Indian J Tuberc; 2023 Jul; 70(3):345-355. PubMed ID: 37562911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.
    Pandey S; Congdon J; McInnes B; Pop A; Coulter C
    Pathology; 2017 Jan; 49(1):70-74. PubMed ID: 27913043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis.
    Mechal Y; Benaissa E; El Mrimar N; Benlahlou Y; Bssaibis F; Zegmout A; Chadli M; Malik YS; Touil N; Abid A; Maleb A; Elouennass M
    BMC Infect Dis; 2019 Dec; 19(1):1069. PubMed ID: 31856744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Anyplex™ II MTB/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens.
    Chumpa N; Kawkitinarong K; Rotcheewaphan S; Sawatpanich A; Petsong S; Tumwasorn S; Suwanpimolkul G
    Mol Biol Rep; 2020 Apr; 47(4):2501-2508. PubMed ID: 32124172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of GeneXpert MTB/RIF and BACTEC-MGIT 960 for the detection of tuberculosis among pneumoconiosis-associated tuberculosis patients].
    Jin Y; Wang HQ; Fan JG; Pang J; Zhang PY; Li T
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2019 Sep; 37(9):690-693. PubMed ID: 31594129
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand.
    Pongpeeradech N; Kasetchareo Y; Chuchottaworn C; Lawpoolsri S; Silachamroon U; Kaewkungwal J
    PLoS One; 2022; 17(7):e0271130. PubMed ID: 35895742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert
    Rasool G; Khan AM; Mohy-Ud-Din R; Riaz M
    Int J Immunopathol Pharmacol; 2019; 33():2058738419827174. PubMed ID: 30791749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience with GeneXpert MTB/RIF assay in the Arkansas Tuberculosis Control Program.
    Patil N; Saba H; Marco A; Samant R; Mukasa L
    Australas Med J; 2014; 7(5):203-7. PubMed ID: 24944716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.
    Cayci YT; Bilgin K; Coban AY; Birinci A; Durupınar B
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):756-759. PubMed ID: 29091135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.